Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGabelli Merger Share News (GMP)

Share Price Information for Gabelli Merger (GMP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 9.00
GMP Live PriceLast checked at -
Gabelli Merger Plus+ is an Investment Trust

To generate total return, consisting of capital appreciation and current income. The Company will seek a secondary objective of the protection of capital, uncorrelated to equity and fixed income markets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Gabelli Merger Plus Outperforms Benchmark Total Return In Maiden Year

Tue, 09th Oct 2018 12:14

LONDON (Alliance News) - Gabelli Merger Plus Trust PLC said Tuesday it outperformed its benchmark, despite a reduced net asset value per share, in its first year listed on London's Main Market.

At the end of the year, June 30, Gabelli's net asset value per share cumulative of income was USD9.84, down from USD9.92 the year before.

The investment manager's net asset value per share total return was 2.8% compared to the company's benchmark, the 3-month US Treasury Bill index, returning 1.3%.

This is Gabelli Merger's first annual report after listing on the Specialist Fund Segment of the Main Market in July 2017.

Gabelli Merger's return was "strong" relative to other merger arbitrage indices such as the S&P Merger Arbitrage Index, which gained 1.5% and the CS Merger Arbitrage Liquid Index, gaining 2.3% in the period.

Global merger & acquisition activity totalled USD2.5 trillion in the first six months of 2018, the strongest first half on record and a 61% increase year-on-year, which Gabelli Merger said drove the company's performance.

In particular, the agreed acquisitions of American health care companies Aetna Inc and Foundation Medicine Inc and American real estate investor Gramercy Property Trust were highlights in Gabelli Merger's portfolio.

Looking ahead, the company remains "optimistic". Gabelli Merger believes the components are in place for "positive shareholder returns".

Rising deal risk premiums and rising interest rates combined with "healthy" deal volumes provide a "fertile picking ground".

During the year, the company paid out dividends of USD0.47 per share.

Shares in Gabelli Merger Plus were untraded Tuesday but last closed at 133.50 pence each.

More News
13 Aug 2018 13:22

Gabelli Merger Says No Material Reason For Recent Share Price Movement

LONDON (Alliance News) - Gabelli Merger Plus+ Trust PLC said Monday its recent share price activity was a result of near-term portfolio rebalancing by select shareholders, low August stock market

Read more
20 Jul 2018 10:42

Gabelli Merger Non-Executive Director Paolo Vicinelli Steps Down

LONDON (Alliance News) - Gabelli Merger Plus+ Trust PLC on Friday said Non-Executive Director Paolo Vicinelli will not stand for re-election at the annual general meeting, but ill remain a and him

Read more
14 Mar 2018 13:12

BP Marsh Has Strong February After Positive Results - QuotedData

LONDON (Alliance News) - Net asset value moves during February were a result of dollar strength rather than a change in the local currency value of assets, according to a by a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.